SMAD2 and lung carcinoma: Mechanistically, TMED10 may exert tumor-promoting effects via disruption of TGF-β receptor complex formation, as observed in lung cancer models, where it attenuates Smad2 activation and downstream TGF-β signaling pathways [73, 74].